Abstract
Between February 1993 and May 1994 we studied the prevalence of fungal vulvovaginitis among women attending the Obstetric and Gynecology Clinic of the University of Ancona. Out of the 222 patients, 18 (8.2%) women had symptomatic vaginitis and 24 (10.8%) were carriers. Candida albicans was the species most frequently isolated (44.2%), followed by Torulopsis glabrata (28%) and Saccharomyces cerevisiae (16.2%), from symptomatic and carrier patients. The activity of acid proteinase was determined for C. albicans isolated from both symptomatic and carrier patients. All 13 carriers showed low activity for aspartyl proteinase (score 1+), while 5 of 6 symptomatic patients showed higher activity (score 2+), with a significant difference (p = 0.026). In general, isolates of T. glabrata and S. cerevisiae were less susceptible in vitro to fluconazole than isolates of C. albicans. We did not find any differences in fluconazole MIC results among the C. albicans strains isolated from symptomatic and carrier patients. On the other hand, the fluconazole MICs of T. glabrata and S. cerevisiae isolates showed statistically significant differences between symptomatic and carrier patients (p = 0.009 and p = 0.000, respectively). The differences in proteinase secretion between the isolates from symptomatic and carrier patients suggest a correlation between proteinase production and vaginal candidiasis caused by C. albicans. Torulopsis glabrata, however, was found to be the most common causative agent of vaginitis (7 out 19 episodes), followed by C. albicans (6 out of 19 episodes). Due to the varying patterns of antifungal susceptibility, mainly to fluconazole for the yeast isolates considered in this study, an in vitro susceptibility testing program might be useful for monitoring the outcome of this infection.
Similar content being viewed by others
References
Barchiesi F, Colombo AL, McGough DA, Rinaldi MG. Comparative study of macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J Clin Microbiol 1994; 32: 2494–2500.
Barchiesi F, Morbiducci V, Ancarani F, Scalise G. Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV infected patients. Eur J Epidemiol 1993; 9: 455–456.
Cassone A, De Bernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase and vulvovaginal candidosis. J Infect Dis 1987; 156: 777–783.
Center for Disease Control. Nonreported sexually transmitted diseases. MMWR 1979; 28: 61.
De Bernardis F, Agatensi L, Ross IK, Emerson GW, Lorenzini R, Sullivan AP, Cassone A. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis 1990; 161: 1276–1283.
De Bernardis F, Boccanera M, Rainaldi L, Guerra CE, Quinti I, Cassone A. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur J Epidemiol 8: 362–367.
Kwon-Chung KJ, Lehman D, Good C, Magee PT. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 1985; 49: 571–575.
Odds FC. Ecology of Candida and epidemiology of candidosis. In Odds FC, Candida and candidosis: A review and bibliography 2nd. ed, London: Ballière Tindall, 1988: 68–92.
Odds FC. Candidosis of the genitalia. In Odds FC, Candida and candidosis: A review and bibliography, 2n. ed. London: Ballière Tindall, 1988: 124–135.
Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1–8.
Rüchel R, Uhlemann K, Boning B. Secretion of acid proteinases by different species of the genus Candida. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983; 255: 537–548.
Sobel JD. Vaginal infections in adult women. Med Clin North Am 1990; 74: 1573–1602.
White DJ, Johnson EM, Warnock WD. Management of persistance vulvovaginal candidosis due to azoleresistant Candida glabrata. Genitourin Med 1993; 69: 112–114.
Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arzeni, D., Del Poeta, M., Simonetti, O. et al. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. Eur J Epidemiol 13, 447–450 (1997). https://doi.org/10.1023/A:1007366722235
Issue Date:
DOI: https://doi.org/10.1023/A:1007366722235